Invention Grant
- Patent Title: Heterocyclic inhibitors of PTPN11
-
Application No.: US15607174Application Date: 2017-05-26
-
Publication No.: US10280171B2Publication Date: 2019-05-07
- Inventor: Philip Jones , Barbara Czako , Jason Cross , Paul Leonard , Faika Mseeh , Connor Austin Parker
- Applicant: Board of Regents, The University of Texas System
- Applicant Address: US TX Austin
- Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; A61K31/501 ; C07D487/04 ; C07D519/00
Abstract:
The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.
Public/Granted literature
- US20170342078A1 HETEROCYCLIC INHIBITORS OF PTPN11 Public/Granted day:2017-11-30
Information query
IPC分类:
